How to research COVID-19 host genetics?
Congenica’s COVID-19 host genetics analysis module, enables researchers to identify genes that influence COVID-19 susceptibility, progression and severity.
Inclusion in AJHG “Year in Review” 2020
The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, which includes a study featuring Congenica.
Charles’ Story
Our daughter Imogen was born in 2012 at 30 weeks, and spent her first month in intensive care.
The complexity of epilepsy - an overview
My name is Charles, and I'm both a Genome Scientist and the Patient Advocacy & Engagement Lead at Congenica, Cambridge, UK
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General.
Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations
Our plans for the future: a video message from our CEO and Chairman
Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise.
The culture changes needed to mainstream genomics
We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics.
The importance of improving the efficiency of genetic analysis
We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis.
The benefits and challenges of mainstreaming genomics and precision medicine
We spoke to a number of industry leaders to discuss their thoughts on the benefits and challenges of mainstreaming genomics and precision medicine